Month: May 2024

WASHINGTON, May 8, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the...

First Quarter 2024 Revenue was $576.6 Million, down 8.9 PercentOperating Income was $22.7 Million or 3.9 Percent of Revenue($37.9 Million...

Contacts Investors Jake Graves Senior Manager, Investor Relations The Trade Desk ir@thetradedesk.com Media Melinda Zurich VP, Communications The Trade Desk...

FOSTER CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...

Contacts Investor Contact Trent Thrash IR@taskus.com Media Contact Heidi Lemmetyinen heidi.lemmetyinen@taskus.com TaskUs, Inc. (Nasdaq: TASK), a leading provider of outsourced...

Generated $24.7 million in net product sales of XDEMVY®, an 89% increase over Q4 2023, and delivered approximately 26,000 bottles...

ROCKVILLE, Md., May 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

SZN-043 Phase 1a clinical trial results to be presented at the 2024 European Association for the Study of the Liver...

 Net Investment Income of $0.44 Per Share;Declared Quarterly Distribution of $0.41 Per Share;NAV Appreciation and Solid Portfolio Credit QualityRead more...

Seventh Straight Quarter of Record Revenue and 20% Growth Year-Over-Year Contacts SkyWater Investor Contact: Claire McAdams | claire@headgatepartners.com SkyWater Media...

SALT LAKE CITY, May 8, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal...

REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a...

Contacts Investor & Media Inquiries: (888) 393-8248 or investorinquiries@sabrahealth.com Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq:...

Goal to treat 40-60 patients in 2024 in four trials across seven indications in oncology, B-cell mediated autoimmune diseases, and...

Contacts Safety Insurance Group, Inc. Office of Investor Relations 877-951-2522 InvestorRelations@SafetyInsurance.com Safety Insurance Group, Inc. (NASDAQ:SAFT) (“the Company” or “Safety”)...

REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...

Exceeded high-end of Q1 guidance range for both Storage and Solar installationsStorage Capacity Installed of 207 Megawatt hours in Q1,...

SAN DIEGO, May 8, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class...

CORAL GABLES, Fla., May 8, 2024 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the...

Company to Present and Participate in Investor Meetings During 24th Annual B. Riley Institutional Investor Conference on May 22-23, 2024 LOS...

ROCKVILLE, Md., May 8, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced financial results for the first quarter ending...

BOCA RATON, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions...

LOS ANGELES, May 08, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site...

Contacts Investor Relations Meg Nunnally, 206-576-8610 ir@redfin.com Public Relations Mariam Sughayer, 206-876-1322 press@redfin.com Redfin Corporation (NASDAQ: RDFN) today announced that...

PENNSAUKEN, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of business and technology...

The 14th edition of the wage study finds mother’s economic value increased 5% in the last year Contacts Media contact:...

- Global year-over-year revenue growth of 5% as reported and 6% in constant currency, excluding COVID-19 revenue - - Cost...

Reports Net Investment Income of $0.67 Per Share and Net Asset Value of $22.57 Per ShareContinued Share Repurchase Program: Total...

Raises full year revenue guidance due to greater pharma testing demand Contacts Investor Relations Contact: Caroline Corner investors@personalis.com 646-277-1279 Media:...

Net cash used in operating and investing activities was $73.2 million in the first quarter of 2024; quarter-end cash and...

Strong operating execution in Q1, increasing full year Adjusted EBITDA Guidance Contacts Investor Relations Contact Lois Perkins, Head of Investor...

Dr. Aric Coffman joins P3 Health Partners as CEO Total revenue growth of 29% year-over-year Reaffirming 2024 guidance Anticipates reaching...

GERMANTOWN, Md., May 8, 2024 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and...

TAMPA, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced that it intends to offer,...

OSWEGO, N.Y., May 08, 2024 (GLOBE NEWSWIRE) -- Pathfinder Bancorp, Inc. (“Pathfinder”) (NASDAQ: PBHC) today announced that Walter F. Rusnak,...

Contacts Investor Contact Jim Mazzola Investor Relations jmazzola@outsetmedical.com Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology...

SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused...

HOLLYWOOD, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (Nasdaq GS: NVEE) ("NV5" or the "Company"), a provider...

-- Revenue increased to $18.1 million in Q1 2024, a 25% increase over Q1 2023 ---- Extended the maturity date...